Opioid Predictive Analytic Program  


Department of Defense Opioid Registry (DORS): A Predictive Analytics Model to Improve Care in the Military   Health System  

Drug overdose deaths reached record levels in 2014, and at least half of those deaths involved prescription   drugs.2 Opioids are the most common prescription drugs involved in these deaths. Prescription opioid sales have quadrupled in   the United States since 1999, and so have the number of deaths from prescription opioid overdoses.4 It was estimated from   1999 to 2014, more than 165,000 people died from overdose related to prescription opioids.3 Despite the increase use of   opioids, the overall amount of pain Americans report has not changed.5There have not been long term studies demonstrating   that opioids control chronic pain effectively. Many people become tolerant to opioids and require higher amounts of the drug   and approximately 2 million in the United States abuse or become addicted to opioids. The Military Health System (MHS) is a   leader in efforts to address this problem with a variety of innovative approaches. These include development and   implementation of the DoD Opioid Registry System (DORS). DORS supports users of multiple stakeholders from the pain,   addiction, behavioral health and pharmacy communities to improve safety and quality of care of patients on opioid   prescriptions.  DORS is a  patient-focused initiative which  offers distinct views (e.g. provider, management, and risk) to support   actionable activities related to prevention of opioid misuse, management of daily opioid use,  risk stratification and assessment.
  Opioid  categories and morphine equivalence conversions are defined and categorized in collaboration with the DoD Pharmacy   Operations Division (POD) and VA pharmacy communities.  Healthcare utilization factors (number of ED  visits, distinct providers   seen, etc.) as well as risk stratification variables are incorporated in a predictive analytics model to develop relevant risk scores.    Reports (e.g. opioid use, opioids and benzodiazepines etc.) provide key aggregate measures and enable leadership to detect   trends and assess effectiveness of opioid safety programs.  This registry is a successful example of leveraging existing technology   (Carepoint MHS Population Health Portal), adopting standards, and building partnerships from both within and outside the DoD   to address a high priority health issue.